Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4168849
Max Phase: Preclinical
Molecular Formula: C11H11FO3
Molecular Weight: 210.20
Molecule Type: Small molecule
Associated Items:
ID: ALA4168849
Max Phase: Preclinical
Molecular Formula: C11H11FO3
Molecular Weight: 210.20
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)[C@@H](Cc1ccc(F)cc1)[C@@H]1CO1
Standard InChI: InChI=1S/C11H11FO3/c12-8-3-1-7(2-4-8)5-9(11(13)14)10-6-15-10/h1-4,9-10H,5-6H2,(H,13,14)/t9-,10-/m0/s1
Standard InChI Key: DLXNRUUQYRZAOY-UWVGGRQHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 210.20 | Molecular Weight (Monoisotopic): 210.0692 | AlogP: 1.47 | #Rotatable Bonds: 4 |
Polar Surface Area: 49.83 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.95 | CX Basic pKa: | CX LogP: 1.99 | CX LogD: -1.20 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.77 | Np Likeness Score: 0.25 |
1. Testero SA, Granados C, Fernández D, Gallego P, Covaleda G, Reverter D, Vendrell J, Avilés FX, Pallarès I, Mobashery S.. (2017) Discovery of Mechanism-Based Inactivators for Human Pancreatic Carboxypeptidase A from a Focused Synthetic Library., 8 (10): [PMID:29057062] [10.1021/acsmedchemlett.7b00346] |
Source(1):